다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Avenue Therapeutics Inc (ATXI)
Avenue Therapeutics Inc (ATXI) 뉴스

ATXI

Avenue Therapeutics (ATXI)

Avenue Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ATXI

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	21:30	GlobeNewswire Inc.	Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/05/13	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/05/11	05:53	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/05/11	05:52	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/04/29	21:00	GlobeNewswire Inc.	Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/04/24	20:30	GlobeNewswire Inc.	Avenue Therapeutics Announces Reverse Stock Split	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/03/25	21:30	GlobeNewswire Inc.	Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/03/19	05:05	GlobeNewswire Inc.	Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/03/15	21:15	GlobeNewswire Inc.	Avenue Therapeutics Receives Positive Listing Determination from Nasdaq	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/03/11	21:00	GlobeNewswire Inc.	Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/03/09	06:31	Edgar (US Regulatory)	Form PRE 14C - Other preliminary information statements	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/03/09	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/02/22	22:30	GlobeNewswire Inc.	Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/02/02	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/01/29	22:00	Edgar (US Regulatory)	Form DEF 14C - Other definitive information statements	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/01/25	06:11	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/01/18	07:05	Edgar (US Regulatory)	Form PRE 14C - Other preliminary information statements	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/01/12	20:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/01/11	22:00	GlobeNewswire Inc.	Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/01/09	07:28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/01/05	23:15	GlobeNewswire Inc.	Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/01/04	22:30	GlobeNewswire Inc.	Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol	NASDAQ:ATXI	Avenue Therapeutics Inc
2024/01/02	22:30	GlobeNewswire Inc.	Avenue Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)	NASDAQ:ATXI	Avenue Therapeutics Inc
2023/12/14	06:03	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ATXI	Avenue Therapeutics Inc
2023/12/14	06:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATXI	Avenue Therapeutics Inc
2023/12/01	22:30	GlobeNewswire Inc.	Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting	NASDAQ:ATXI	Avenue Therapeutics Inc
2023/11/29	06:05	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ATXI	Avenue Therapeutics Inc
2023/11/29	06:01	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ATXI	Avenue Therapeutics Inc
2023/11/25	03:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATXI	Avenue Therapeutics Inc
2023/11/14	06:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ATXI	Avenue Therapeutics Inc

검색 관련기사 보기:NASDAQ:ATXI

1 2 3 4 5 6 7 8 9 10 다음 >>

Bank of America

Financial Select Sector

US Dollar vs Euro

US Dollar vs Yen

Energy Select Sector SPDR

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관